282 related articles for article (PubMed ID: 2096488)
1. Increased heparin cofactor II levels in women taking oral contraceptives.
Toulon P; Bardin JM; Blumenfeld N
Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
[TBL] [Abstract][Full Text] [Related]
2. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
[TBL] [Abstract][Full Text] [Related]
3. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
4. Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.
Massouh M; Jatoi A; Gordon EM; Ratnoff OD
J Lab Clin Med; 1989 Dec; 114(6):697-9. PubMed ID: 2592856
[TBL] [Abstract][Full Text] [Related]
5. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
[TBL] [Abstract][Full Text] [Related]
6. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus.
Toulon P; Lamine M; Ledjev I; Guez T; Holleman ME; Sereni D; Sicard D
Thromb Haemost; 1993 Nov; 70(5):730-5. PubMed ID: 8128426
[TBL] [Abstract][Full Text] [Related]
7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
8. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic risk factors and oral contraception.
Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
[TBL] [Abstract][Full Text] [Related]
11. Coagulation studies in women using combination type of oral contraceptives.
Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
13. [Oral contraceptive agents and antithrombin III].
Kamenov V; Nalbanski B
Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
Pabinger I; Schneider B
Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of oral contraceptives: a review.
Stubblefield PG
Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
[TBL] [Abstract][Full Text] [Related]
16. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
17. Haemostasis and oral contraceptives.
Farag A; Bottoms SF; Mammen EF; Hosni M; Ali A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):340-5. PubMed ID: 2465227
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
19. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]